Back to News
Market Impact: 0.1
Biotech Firm Colossal Set to Return Extinct Bird’s Egg to New Zealand
Source: Bloomberg
Healthcare & BiotechTechnology & Innovation
Colossal Biosciences Inc., a biotech firm seeking to bring extinct species back to life, acquired a rare moa egg. The company plans to return the flightless bird egg to its native New Zealand; no financial terms were reported.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- BlackRock, GIC among investors chasing Indian telecom major Jio's IPO as anchor bids top $26 billion
- Nscale, Anthropic Eye $45 Billion Cloud Deal as AI Trade Rebounds
- Gartner analyst behind tech rout: AI returns are not yet large enough to justify neocloud build-out
- Alibaba Backs Chinese Robovan Maker in $400 Million Fundraising
- X-Energy CEO on Amazon, AEP Nuclear Data Center Deal
- Ukraine’s drones lose their Starlink link above 100 mph. Musk, Rubio and Trump all say it wasn’t them
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Advanced Search Filters, Redesigned Ticker Dashboard, and Improved Search Experience
- How to Build an Automated Research Process for a Fund